[go: up one dir, main page]

MXPA06001115A - Un proceso nuevo para la preparacion de imipenem. - Google Patents

Un proceso nuevo para la preparacion de imipenem.

Info

Publication number
MXPA06001115A
MXPA06001115A MXPA06001115A MXPA06001115A MXPA06001115A MX PA06001115 A MXPA06001115 A MX PA06001115A MX PA06001115 A MXPA06001115 A MX PA06001115A MX PA06001115 A MXPA06001115 A MX PA06001115A MX PA06001115 A MXPA06001115 A MX PA06001115A
Authority
MX
Mexico
Prior art keywords
imipenem
preparation
new process
formula
compound
Prior art date
Application number
MXPA06001115A
Other languages
English (en)
Inventor
Moo Sung Kim
Original Assignee
Choongwae Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choongwae Pharm Co filed Critical Choongwae Pharm Co
Publication of MXPA06001115A publication Critical patent/MXPA06001115A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation
    • C07D477/06Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describe en la presente un compuesto de formula II a continuacion: OH en donde R1 es un grupo p-nitrobencilo o p-metoxibencilo; y R2 y R3 pueden ser identicos o diferentes entre si y cada uno es independientemente un grupo alquilo de 1 a 6 atomos de carbono o arilo, o un derivado del mismo, y un proceso para la preparacion del compuesto de formula II. Se describe adicionalmente un proceso para preparar imipenem de formula I a continuacion: mediante la utilizacion del compuesto de formula II.
MXPA06001115A 2003-12-09 2004-12-09 Un proceso nuevo para la preparacion de imipenem. MXPA06001115A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20030088857 2003-12-09
PCT/KR2004/003224 WO2005056553A1 (en) 2003-12-09 2004-12-09 A new process for preparation of imipenem

Publications (1)

Publication Number Publication Date
MXPA06001115A true MXPA06001115A (es) 2006-04-11

Family

ID=36642326

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06001115A MXPA06001115A (es) 2003-12-09 2004-12-09 Un proceso nuevo para la preparacion de imipenem.

Country Status (14)

Country Link
US (1) US7507814B2 (es)
EP (1) EP1692135A4 (es)
JP (1) JP4500814B2 (es)
KR (1) KR100667373B1 (es)
CN (1) CN100383142C (es)
AU (1) AU2004296261B2 (es)
BR (1) BRPI0413057B8 (es)
CA (1) CA2531578C (es)
MX (1) MXPA06001115A (es)
NO (1) NO20062602L (es)
NZ (1) NZ547641A (es)
RU (1) RU2314308C2 (es)
WO (1) WO2005056553A1 (es)
ZA (1) ZA200604446B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03010498A (es) * 2001-05-18 2004-05-27 Ranbaxy Lab Ltd Proceso para la preparacion de imipenem.
AU2004296261B2 (en) * 2003-12-09 2007-08-23 Choongwae Pharm. Co. A new process for preparation of imipenem
CN102690266B (zh) * 2011-09-02 2014-06-18 深圳市海滨制药有限公司 一种制备厄他培南钠的方法
CN108623598A (zh) * 2018-05-21 2018-10-09 重庆天地药业有限责任公司 一种亚胺培南中间体及亚胺培南的制备方法
CN115932077B (zh) * 2022-11-15 2025-06-10 泊诺(天津)创新医药研究有限公司 一种培南类抗生素药物杂质聚合物的鉴别及含量测定方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235920A (en) * 1975-11-21 1980-11-25 Merck & Co., Inc. N-Alkylated derivatives of thienamycin
CH628051A5 (en) * 1975-11-21 1982-02-15 Merck & Co Inc Process for the preparation of N-alkylated derivatives of thienamycin
US4172144A (en) * 1976-10-18 1979-10-23 Merck & Co., Inc. Schiff's base derivatives of thienamycin
US4150145A (en) * 1977-09-15 1979-04-17 Merck & Co., Inc. N-alkylated derivatives of thienamycin sulfoxide and sulfone
US4292436A (en) 1980-06-25 1981-09-29 Merck & Co., Inc. Process for the preparation of N-protected N-formimidoyl 2-aminoethanethiol
US4845261A (en) 1987-05-11 1989-07-04 Merck & Co., Inc. Process for bis(substituted phenyl) phosphorohalidates
US4894450A (en) * 1987-05-11 1990-01-16 Merck & Co., Inc. Process for 2-(aminoalkylthio) carbapenems
DK0900797T3 (da) * 1996-04-26 2002-09-09 Sankyo Co Et 1-methylcarbapenemderivat
IN191798B (es) * 2000-11-03 2004-01-03 Ranbaxy Lab Ltd
ITMI20010077A1 (it) * 2001-01-17 2002-07-18 Acs Dobfar Spa Procedimento per la produzione dell'imipenem
MXPA03010498A (es) * 2001-05-18 2004-05-27 Ranbaxy Lab Ltd Proceso para la preparacion de imipenem.
AU2004296261B2 (en) * 2003-12-09 2007-08-23 Choongwae Pharm. Co. A new process for preparation of imipenem

Also Published As

Publication number Publication date
AU2004296261A1 (en) 2005-06-23
ZA200604446B (en) 2007-10-31
BRPI0413057A (pt) 2006-10-17
US20060167243A1 (en) 2006-07-27
CA2531578A1 (en) 2005-06-23
KR100667373B1 (ko) 2007-01-10
CA2531578C (en) 2008-10-07
NO20062602L (no) 2006-08-31
EP1692135A1 (en) 2006-08-23
JP2007501838A (ja) 2007-02-01
BRPI0413057B1 (pt) 2018-02-06
RU2314308C2 (ru) 2008-01-10
CN1829716A (zh) 2006-09-06
RU2006102664A (ru) 2006-08-10
BRPI0413057B8 (pt) 2021-05-25
US7507814B2 (en) 2009-03-24
KR20050056161A (ko) 2005-06-14
AU2004296261B2 (en) 2007-08-23
WO2005056553A1 (en) 2005-06-23
CN100383142C (zh) 2008-04-23
JP4500814B2 (ja) 2010-07-14
NZ547641A (en) 2009-02-28
EP1692135A4 (en) 2009-02-25

Similar Documents

Publication Publication Date Title
IL192253A0 (en) Substituted cyclohexylmethyl derivatives
MXPA05013752A (es) Procedimiento e intermediarios para la preparacion de (1r,2s,5s)-6,6-dimetil-3-azabiciclo[3,1,0]exan-2-carboxilatos o sales de los mismos.
MXPA05012799A (es) Compuestos triheterociclicos, composiciones y metodos para tratar cancer o enfermedades virales.
AP1822A (en) Substituted pyridinones as modulators of P38 MAP kinase.
MXPA05008705A (es) Derivados de piridina como compuestos fungicidas.
GB0129476D0 (en) Organic compounds
MY139887A (en) Tetrahydronaphthyridine derivatives and a process for preparing the same.
TW200517393A (en) Processes for the preparation of benzoimidazole derivatives
YU94103A (sh) Novi derivati sulfonske kiseline
WO2009018065A3 (en) Novel glucokinase activators and methods of using same
TNSN04250A1 (en) Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof.
WO2004110976A3 (en) Process for the preparation of aromatic amines
PL1753712T3 (pl) Pochodne aminopropanolu
MXPA06001115A (es) Un proceso nuevo para la preparacion de imipenem.
TW200613292A (en) Benzothiazolium compounds
BG105766A (en) New process for preparing pesticidal intermediates
PL361850A1 (en) Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
AU2003242896A1 (en) Solvent-free process for the preparation of diketopyrrolopyrrole derivatives
SG149005A1 (en) Process for the preparation of thiazolopyrimidines
MY150428A (en) Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same
TW200719889A (en) Amino acid derivatives
WO2005035528A3 (en) Triazole derivatives as antibacterial agents
WO2002046152A3 (de) Coniosetin und derivate davon, verfahren zur herstellung und verwendung derselben
GB0320738D0 (en) Novel process
TW200510448A (en) Novel process and intermediates for preparing 17-halogenated 19-norsteroid compounds

Legal Events

Date Code Title Description
FG Grant or registration